Hyperparathyroidism

American Family Physician

Volumn 69, Issue 2, 2004, Pages 333-339+340

  Taniegra, Edna D ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; BISPHOSPHONIC ACID DERIVATIVE; CALCIMIMETIC AGENT; CALCIUM; LITHIUM; RALOXIFENE; RETINOL; TAMOXIFEN; TAMOXIFEN CITRATE; THEOPHYLLINE; VITAMIN D;

ALGORITHM; ANOREXIA; ANXIETY; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CLINICAL FEATURE; DIET SUPPLEMENTATION; FATIGUE; HORMONE ACTION; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; LONG TERM CARE; MUSCLE WEAKNESS; OSTEOLYSIS; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID TUMOR; PARATHYROIDECTOMY; PATHOGENESIS; PATIENT MONITORING; POSTOPERATIVE CARE; PRIMARY HYPERPARATHYROIDISM; REVIEW; SECONDARY HYPERPARATHYROIDISM; TREATMENT INDICATION;

HUMANS; HYPERPARATHYROIDISM;

EID: 1642499343     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Kearns AE, Thompson GB. Medical and surgical management of hyperparathyroidism. Mayo Clin Proc 2002;77:87-91.
2. Silverberg SJ. Natural history of primary hyperparathyroidism. Endocrinol Metab Clin North Am 2000;29:451-64.
3. Schnatz PF, Curry SL. Primary hyperparathyroidism in pregnancy: evidence-based management. Obstet Gynecol Surv 2002;57:365-76.
4. Potts JT Jr. Diseases of the parathyroid gland and other hyper- and hypocalcemic disorders. In: Harrison TR, Braunwald E. Harrison's Principles of internal medicine. 15th ed. New York: McGraw-Hill, 2001:8-22.
5. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism. In: Williams RH, Wilson JD. Williams Textbook of endocrinology 9th ed. Philadelphia: Saunders, 1998.
6. Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C, et al. Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res 2002;17 (suppl 2):N37-43.
7. Thakker RV. Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 2000;29:541-67
8. Brown EM. Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium. Endocrinol Metab Clin North Am 2000;29:503-22.
9. Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, Kleerekoper M, Neer R, Peacock M, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 2002;17(suppl 2):N2-11.
10. Solimando DA. Overview of hypercalcemia of malignancy. Am J Health Syst Pharm 2001;58(suppl 3):S4-7.
11. Gregerman RI. Selected endocrine problems: disorders of pituitary, adrenal, and parathyroid glands; pharmacologic use of steroids; hypocalcemia and hypercalcemia; water metabolism; hypoglycemia; and hormone use of unproven value. In: Barker LR, Burton JR, Zieve PD, eds. Principles of ambulatory medicine. 5th ed. Baltimore: Williams & Wilkins, 1999:1096-121.
12. Bilezikian JP. Primary hyperparathyroidism. When to observe and when to operate. Endocrinol Metab Clin North Am 2000;29:465-78.
13. Kort KC, Schiller HJ, Numann PJ. Hyperparathyroidism and pregnancy. Am J Surg 1999;177:66-8.
14. Irvin GL III, Carneiro DM. Management changes in primary hyperparathyroidism. JAMA 2000;248:934-6.
15. Lee NC, Norton JA. Multiple-gland disease in primary hyperparathyroidism: a function of operative approach? Arch Surg 2002;137:896-9.
16. Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002;235:665-70.
17. Goss JC, Landerholm R. A changing experience with primary hyperparathyroidism at Group Health Cooperative, Seattle. Am J Surg 2001;181:445-8.
18. Goldstein RE, Blevins L, Delbeke D, Martin WH. Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism. Ann Surg 2000;231:732-42.
19. Dackiw AP, Sussman JJ, Fritsche HA Jr, Delpassand ES, Stanford P, Hoff A, et al. Relative contributions of technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. Arch Surg 2000;135:550-5.
20. Perrier ND, Ituarte PH, Morita E, Hamill T, Gielow R, Duh QY, Clark OH. Parathyroid surgery: separating promise from reality. J Clin Endocrinol Metab 2002;87:1024-9.
21. Lowney JK, Lairmore TC. Endocrine surgery. In: Doherty GM. The Washington manual of surgery. 3d ed. Philadelphia: Lippincott Williams & Wilkins, 2002.
22. Strewler GJ. Medical approaches to primary hyperparathyroidism. Endocrinol Metab Clin North Am 2000;29:523-39, vi.
23. Wells SA Jr, Debenedetti MK, Doherty GM. Recurrent or persistent hyperparathyroidism. J Bone Miner Res 2002;17(suppl 2):N158-62.
24. Marx SJ. Hyperparathyroid and hypoparathyroid disorders [Published corrections appear in N Engl J Med 2001;344:240 and 2001; 344:696]. N Engl J Med 2000;343:1863-75.
25. Marx SJ. Hyperparathyroid and hypoparathyroid disorders [Published corrections appear in N Engl J Med 2001;344:240 and 2001; 344:696]. N Engl J Med 2000;343:1863-75.
26. Marx SJ. Hyperparathyroid and hypoparathyroid disorders [Published corrections appear in N Engl J Med 2001;344:240 and 2001; 344:696]. N Engl J Med 2000;343:1863-75.